Detection of Antiphospholipid Antibodies by Flow Cytometry: Rapid Detection of Antibody Isotype and Phospholipid Specificity

Summary

Laboratory diagnosis of antiphospholipid antibodies is important in patients with clinical features of the antiphospholipid syndrome, such as thrombosis and fetal loss. We have developed a novel method for the detection of antiphospholipid antibodies using flow cytometry. Anionic phospholipids cardiolipin, phosphatidylserine and phosphatidylinositol are coated onto polystyrene beads of different sizes, allowing detection and semiquantitation of their respective phospholipid antibody isotypes. The results of the flow cytometric method closely correlate those of the standardised anticardiolipin enzyme-linked immunosorbent assay (ELISA), but the method is quicker and is versatile in its ability to detect IgG, IgM and IgA antibody isotypes at the same time. The method promises to be useful in evaluating the significance of phospholipid specificity and antibody isotypes in patients with the antiphospholipid syndrome.

• References

• 1 Mueh JR, Herbst KD, Rapaport SI. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 1980; 92: 156-159
• 2 Feinstein DI. Lupus anticoagulant, thrombosis and fetal loss. N Engl J Med 1985; 313: 1348-1350
• 3 Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA. Lupus anticoagulant IgG’s (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemostas 1991; 66: 629-632
• 4 McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta₂ glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124
• 5 Vermylen J, Blockman D, Spitz B, Deckmyn H. Thrombosis and immune disorders. Clinics in Haematol 1986; 15: 1-19
• 6 Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulants. Thromb Haemostas 1991; 65: 320-322
• 7 Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GRV. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii: 1211-1214
• 8 Jouhikainen T, Julkunen H, Vaarala O, Leirisalo-Repo M, Stephans-son E, Vahtera E, Palosuo T, Myllyla G. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients. Blood Coagul Fibrinol 1992; 3: 407-414
• 9 Rosove MH, Brewer P, Runge A, Hirji K. Simultaneous lupus anticoagulant and anticardiolipin assays and clinical detection of antiphospholipids. Am J Hematol 1989; 32: 148-149
• 10 Harris EN, Gharavi AE, Patel S, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215-222
• 11 Harris EN. The second international anticardiolipin standardisation workshop/the Kingston Antiphospholipid Antibody Study (KAPS) Groups. Am J Clin Pathol 1990; 94: 476-484
• 12 Al-Momen A-K, Sulimani R, Harakati M, Gader AG, Mekki M. IgA antiphospholipid and adrenal insufficiency: Is there a link?. Thromb Res 1991; 64: 571-578
• 13 Rote NS, Dostal-Johnson D, Branch DW. Antiphospholipid antibodies and recurrent pregnancy loss: Correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin. Am J Obstet Gynecol 1990; 163: 575-584
• 14 Rauch J, Tannenbaum M, Janoff AS. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemostas 1989; 62: 892-896
• 15 Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ, Barbui T, Zwaal RF, Bevers EM. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-1547
• 16 Tan EM, Cohen AS, Fries JF. The revised criteria for the classification of SLE. Arth Rheum 1982; 25: 1271-1277
• 17 Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardisation and quantitation of results. Clin Exp Immunol 1985; 62: 738-745
• 18 Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AE, Hughes GRV. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody tests. Arch Intern Med 1986; 146: 2153-2156
• 19 Cronin ME, Biswas RM, Vanderstraeton C, Fleischer TA, Klippel JH. IgG and IgM anticardiolipin antibodies in patients with anticar-diolipin associated clinical syndromes. J Rheumatol 1988; 15: 795-798
• 20 Branch WD. Immunologie disease and fetal death. Clin Obstet Gynecol 1987; 30: 295-311
• 21 Lin Y-L, Wang C-T. Activation of human platelets by the rabbit anticardiolipin antibodies. Blood 1992; 80: 3135-3143
• 22 Harris EN, Pierangeli S, Simpson P. A more specific phospholipid antigen for the antiphospholipid syndrome (abstract). Arthritis Rheum 1990; 33: S 163